Bristol-Myers Squibb Co
F:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
P
|
Patterson-UTI Energy Inc
XMUN:PE1
|
US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
C
|
CSL Ltd
XMUN:CSJ
|
AU |
|
F
|
Fortuna Mining Corp
NYSE:FSM
|
CA |
|
V
|
Vulcan Materials Co
SWB:VMC
|
US |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
|
G
|
Gold Fields Ltd
XMUN:EDGA
|
ZA |
|
SPAR Group Ltd
OTC:SGPPY
|
ZA |
|
M
|
Moderna Inc
F:0QF
|
US |
|
Recruit Holdings Co Ltd
F:1RHA
|
JP |
|
A
|
Aon PLC
F:4VK
|
IE |
|
C
|
Continental AG
XMUN:CON
|
DE |
|
Henry Schein Inc
NASDAQ:HSIC
|
US |
|
C
|
Chipotle Mexican Grill Inc
F:C9F
|
US |
|
E
|
Eni SpA
XMUN:ENI
|
IT |
|
D
|
Deutsche Bank AG
F:DBK
|
DE |
|
Orthofix Medical Inc
F:OM2
|
US |
|
U
|
United Parcel Service Inc
DUS:UPAB
|
US |
|
MultiChoice Group Ltd
F:30R
|
ZA |
|
A
|
Agnico Eagle Mines Ltd
F:AE9
|
CA |
|
R
|
Royal Bank of Canada
F:RYC
|
CA |
|
V
|
Vimian Group AB
STO:VIMIAN
|
SE |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
Bankruptcy Probability
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bristol-Myers Squibb Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bristol-Myers Squibb Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bristol-Myers Squibb Co has total debt of 42.4B USD. This includes both short-term (259m USD) and long-term (42.1B USD) debt.
You can find a full breakdown on its Balance Sheet.